Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro

Objectives: Many regions of Africa have experienced lower COVID-19 morbidity and mortality than Europe. Pre-existing humoral responses to endemic human coronaviruses (HCoV) may cross-protect against SARS-CoV-2. We investigated the neutralizing capacity of SARS-CoV-2 spike reactive and nonreactive im...

Полное описание

Библиографические подробности
Главные авторы: James Nyagwange, Bernadette Kutima, Kennedy Mwai, Henry K. Karanja, John N. Gitonga, Daisy Mugo, Yiakon Sein, Daniel Wright, Donwilliams O. Omuoyo, Joyce U. Nyiro, James Tuju, D. James Nokes, Ambrose Agweyu, Philip Bejon, Lynette I. Ochola-Oyier, J． Anthony G. Scott, Teresa Lambe, Eunice Nduati, Charles Agoti, George M. Warimwe
Формат: Статья
Язык:English
Опубликовано: Elsevier 2023-02-01
Серии:International Journal of Infectious Diseases
Предметы:
SARS-CoV-2
Human coronaviruses
Pre-existing antibodies
Spike proteins
Online-ссылка:http://www.sciencedirect.com/science/article/pii/S1201971222006336

Internet

http://www.sciencedirect.com/science/article/pii/S1201971222006336

Схожие документы